Patents by Inventor Yingli Sun

Yingli Sun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11538611
    Abstract: The present disclosure discloses a method for the magnetism stabilizing treatment of a permanent magnet material. The method can include the following steps: providing a permanent magnet material having a positive temperature coefficient of coercivity; magnetizing the permanent magnet material at a temperature T3 with a range of ?200 degree centigrades to 200 degree centigrades; and performing a magnetism stabilizing treatment towards the permanent magnet material with temperature decreased in a range of the temperature T3 to a temperature T4, or at the temperature T3.
    Type: Grant
    Filed: February 19, 2020
    Date of Patent: December 27, 2022
    Assignee: NINGBO INSTITUTE OF MATERIALS TECHNOLOGY AND ENGINEERING, CHINESE ACADEMY OF SCIENCES
    Inventors: Lei Liu, Aru Yan, Zhuang Liu, Xin Zhang, Yingli Sun
  • Patent number: 11335482
    Abstract: The present disclosure discloses a high-temperature-stability permanent magnet material and an application thereof. The microstructure of the permanent magnet material comprises a first magnetic phase and a second magnetic phase; the first magnetic phase is a magnetic phase with uniaxial anisotropy, and the second magnetic phase is a magnetic phase with spin reorientation transition; and the first magnetic phase and the second magnetic phase are isolated from each other; and the absolute value of the temperature coefficient of saturation magnetization intensity of the first magnetic phase is less than 0.02%/° C. By means of the permanent magnet material comprising the first magnetic phase and the second magnetic phase, a positive temperature coefficient of coercivity can be obtained, so that obtaining a low temperature coefficient of coercivity can be targeted, regular and universal.
    Type: Grant
    Filed: September 6, 2019
    Date of Patent: May 17, 2022
    Assignee: NINGBO INSTITUTE OF MATERIALS TECHNOLOGY AND ENGINEERING, CHINESE ACADEMY OF SCIENCES
    Inventors: Lei Liu, Zhuang Liu, Aru Yan, Xin Zhang, Yingli Sun, Dong Li
  • Publication number: 20200194152
    Abstract: The present disclosure discloses a method for the magnetism stabilizing treatment of a permanent magnet material. The method can include the following steps: providing a permanent magnet material having a positive temperature coefficient of coercivity; magnetizing the permanent magnet material at a temperature T3 with a range of ?200 degree centigrades to 200 degree centigrades; and performing a magnetism stabilizing treatment towards the permanent magnet material with temperature decreased in a range of the temperature T3 to a temperature T4, or at the temperature T3.
    Type: Application
    Filed: February 19, 2020
    Publication date: June 18, 2020
    Inventors: Lei LIU, Aru Yan, Zhuang Liu, Xin Zhang, Yingli Sun
  • Patent number: 10648039
    Abstract: Disclosed is a use of methylation sites as a disease diagnosis marker, in particular relating to a use of methylation sites in a Y chromosome as a prostate cancer diagnosis marker. More particularly, the method and criterion for screening methylation sites in chromosomes associated with a disease are established in the present invention, and using prostate cancer as an example, six methylation sites in the Y chromosome associated with the prostate cancer diagnosis are screened out. Methylation sites in the Y chromosome screened can be used for early and rapid diagnosis of the disease as a prostate cancer diagnosis marker.
    Type: Grant
    Filed: December 30, 2015
    Date of Patent: May 12, 2020
    Assignee: WUXI SHENRUI BIO-PHARMACEUTICALS CO., LTD.
    Inventors: Yingli Sun, Lushuai Yao
  • Publication number: 20200005974
    Abstract: The present disclosure discloses a high-temperature-stability permanent magnet material and an application thereof. The microstructure of the permanent magnet material comprises a first magnetic phase and a second magnetic phase; the first magnetic phase is a magnetic phase with uniaxial anisotropy, and the second magnetic phase is a magnetic phase with spin reorientation transition; and the first magnetic phase and the second magnetic phase are isolated from each other; and the absolute value of the temperature coefficient of saturation magnetization intensity of the first magnetic phase is less than 0.02%/° C. By means of the permanent magnet material comprising the first magnetic phase and the second magnetic phase, a positive temperature coefficient of coercivity can be obtained, so that obtaining a low temperature coefficient of coercivity can be targeted, regular and universal.
    Type: Application
    Filed: September 6, 2019
    Publication date: January 2, 2020
    Inventors: Lei LIU, Zhuang LIU, Aru YAN, Xin ZHANG, Yingli SUN, Dong LI
  • Publication number: 20170362663
    Abstract: Disclosed is a use of methylation sites as a disease diagnosis marker, in particular relating to a use of methylation sites in a Y chromosome as a prostate cancer diagnosis marker. More particularly, the method and criterion for screening methylation sites in chromosomes associated with a disease are established in the present invention, and using prostate cancer as an example, six methylation sites in the Y chromosome associated with the prostate cancer diagnosis are screened out. Methylation sites in the Y chromosome screened can be used for early and rapid diagnosis of the disease as a prostate cancer diagnosis marker.
    Type: Application
    Filed: December 30, 2015
    Publication date: December 21, 2017
    Inventors: Yingli Sun, Lushuai Yao
  • Publication number: 20130267594
    Abstract: A method to inhibit tissue injury in a subject resulting from exposure to radiation is provided. The method involves administering to the subject a prolyl hydroxylase (PH) inhibitor in an amount effective to inhibit tissue injury caused by radiation exposure of the subject. The invention also involves a screen for PH inhibitors that inhibit tissue damage resulting from exposure to radiation. Compounds that inhibit the enzymatic activity of PHs are tested for their ability to protect against radiation damage.
    Type: Application
    Filed: September 14, 2011
    Publication date: October 10, 2013
    Applicant: DANA-FARBER CANCER INSTITUTE INC.
    Inventors: Brendan D. Price, Yingli Sun